$CROX

Goldman Sachs raises Crocs stock price target on growth outlook

Goldman Sachs raised its price target on Crocs (CROX) to $128 from $95, citing stronger growth, improved profitability, and a positive outlook. The stock has surged 75.7% year-to-date. Crocs reported stronger-than-expected Q3 results, with adjusted earnings of $3.69 per share and revenue of $1.04 billion, raising its full-year outlook. The HEYDUDE brand showed positive performance after two years of negative results.

Original reporting
Published Oct 30, 2026, 9:22 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 9:29 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$CROX
Bullish
high confidence
Mentioned
$CROX
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$CROXBullishMed
01

Why it matters

The target raise could prompt short covering and modest buying, but the Sell rating tempers enthusiasm.

02

Market read

Analyst target increase is a fresh catalyst for CROX, offering a modest trading edge.

03

What to watch

Potential inventory challenges and reliance on the HEYDUDE brand turnaround could temper upside.

Relevance 7/10Novelty 7/10Timing: today

Background

Goldman Sachs updated its valuation model for Crocs after recent earnings beat and brand momentum.

Company-level read

Ticker impact

$CROXBullishHigh confidence
Context

Goldman Sachs raised its price target on Crocs to $128 from $95, maintaining a Sell rating.

Expected impact

likely upward pressure as investors price in higher target

Evidence & confidence

Analyst target increase signals improved growth outlook, which can attract buying interest.

Market effects

May lift sentiment for the broader footwear and consumer discretionary sector.

U.S. consumer stocks could see modest gains.

Limited to U.S. markets; no direct global impact.

Counterpoint

The Sell rating suggests risks remain; investors may stay cautious despite the higher target.

Key entities

  • Goldman Sachs

    Investment bank providing the new price target.

  • Crocs Inc.

    Footwear manufacturer whose stock is being analyzed.

Related articles

$CROXMed

UBS raises Crocs stock price target to $145 on strong results

UBS raised its price target on Crocs (CROX) to $145 from $120, citing strong Q3 results and raised guidance. The stock has surged 26% in a week. UBS noted macro uncertainty but sees balanced risk. Crocs reported adjusted earnings of $3.69 per share and revenue of $1.04B, exceeding expectations. Goldman Sachs also raised its target to $128 but maintained a Sell rating.

$CROXHighAI 9/10

"I thought ugly shoes were a thing of the past"... Crocs shares stage stunning turnaround after plunging 30%

Crocs shares surged 25.54% to $150.26 after strong Q3 results and an upgraded full-year outlook. Adjusted EPS of $3.69 beat estimates, and revenue reached $1.04 billion. HEYDUDE, a subsidiary, saw a 6.1% revenue increase. CEO Andrew Rees cited growth across brands and regions. Last year, shares plunged 30% due to weak guidance and market trends.

$CROXHighAI 9/10

Why Crocs Stock Skyrocketed Today

Crocs (CROX) stock rose 25% after Q3 revenue of $1B (+4.6% YoY) and EPS of $3.69 beat estimates. Sales grew in direct-to-consumer and international markets, with HeyDude brand rebounding. Management expects Q4 growth acceleration and raised EPS guidance to $3.25-$3.45.